We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Becket Invest Plc | LSE:TAB | London | Ordinary Share | GB00BMWKKL25 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.20 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Blank Checks | 0 | -2.27M | -2.7622 | 0.00 | 9.84k |
RNS No 7759p THERAPEUTIC ANTIBODIES INC 1st July 1998 THERAPEUTIC ANTIBODIES INC. The Company was informed on June 30, 1998 that on that day Dr. Harry Browne exercised 197,500 options at USD 1.25 per share. In lieu of a cash payment to the company for the exercise of the options, Dr. Browne exchanged 104,167 common shares valued at USD 2.37 per share. On the same day Dr Harry Browne was granted options over 100,000 shares of Common Stock at USD 2.40 per share for nil consideration exercisable between 30 June 1998 and 30 June 2008. Dr Browne's resultant beneficial holding in shares of common stock is now 215,622, and the total number of shares over which Dr Browne holds options is 115,000. END RDSFCDCDODKDFOK
1 Year Becket Invest Chart |
1 Month Becket Invest Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
